Introduction
The matrix metalloproteinases (MMPs), a family of zinc-and calcium-dependent endopeptidases, are hostderived proteolytic enzymes involved in remodeling of the extracellular matrix and basement membrane during the progression of periodontal disease. In chronic periodontitis, levels of active MMP-2 (72/67-kDa; gelatinase A) and MMP-9 (92/84-kDa; gelatinase B) are elevated in gingival tissue, gingival crevicular fluid, and saliva (1-2), and thus serve as biomarkers of the clinical severity of periodontal disease. These enzymes are mainly produced by gingival epithelial cells, fibroblasts, polymorphonuclear leukocytes, monocytes/macrophages, and endothelial cells (3) . They act principally by degrading basement membrane type IV collagen and gelatin (4) .
Gingival fibroblasts are the predominant cell type in periodontal connective tissue. They produce components of the extracellular matrix and enzymes for matrix degradation that lead to inflammatory periodontal disease. Considerable evidence from in vitro studies has demon-Suppressive effect of ethanolic Kaempferia pandurata Roxb. extract on matrix metalloproteinase-2 expression in Porphyromonas gingivalis-treated human gingival fibroblasts in vitro Yanti 1) and Jae-Kwan Hwang Original strated that fibroblasts obtained from healthy and inflamed periodontal tissues differ in cell size and shape, proliferative rate, collagen production, and expression of growth factor receptors (5) (6) . It has been reported that Gram-negative periodontopathogens colonize gingival pockets including fibroblasts and form gingival plaque during periodontal disease progression. Porphyromonas gingivalis, a major etiologic agent of chronic periodontitis, possesses several virulence factors (e.g., gingipain, lipopolysaccharide, and fimbriae) and causes periodontal tissue destruction by triggering secretion and activation of MMPs, including MMP-2 and MMP-9 (7) (8) (9) (10) (11) . MMP activity is tightly regulated by gene expression, proenzyme activation, and inhibition of active enzymes by specific tissue inhibitors of metalloproteinase (TIMPs). An imbalance between activated MMPs and their respective endogenous TIMPs promotes extracellular matrix degradation during periodontitis (4). Thus, inhibition of MMP expression is an attractive strategy in chemical periodontal therapy. A synthetic MMP inhibitor, doxycycline, has entered development, but its clinical efficacy remains unclear (12) . Therefore, the evaluation of natural therapeutic candidates offers an opportunity to identify MMP inhibitors. Kaempferia pandurata Roxb. is an edible medicinal plant known as temu kunci in Indonesia and krachai in Thailand. It has been traditionally used in culinary and folk medicine for treatment of dental caries, colic disorder, fungal infection, dry cough, rheumatism, and muscle pain (13) . However, its effect on controlling periodontal inflammation via inhibition of MMP expression has not been explored. We investigated the inhibitory effect of K. pandurata extract on MMP-2 expression in human gingival fibroblasts exposed to P. gingivalis in vitro. Then, we examined if K. pandurata extract interfered with signaling pathways involved in MMP-2 expression in this system.
Materials and Methods

Plant materials and reagents
Dried rhizomes of K. pandurata Roxb. were collected in Jakarta, Indonesia, and identified by Dr. Nam-In Baek, Department of Oriental Medicinal Materials and Processing, Kyunghee University (Yongin, Korea). A voucher specimen (H082) was deposited in the Department of Biotechnology, Yonsei University (Seoul, Korea). The ground K. pandurata Roxb. (100 g) was extracted twice with 95% ethanol (400 ml), and the extract (11.95 g) was used for the experiments. P. gingivalis ATCC 33277 was purchased from the American Type Culture Collection (Manassas, VA, USA). The protease inhibitors 4-(2-aminoethyl) benzenesulfonyl fluoride, N-ethylmaleimide, o-phenanthroline, and ethylenediaminetetraacetic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). Inhibitors of MMP (GM6001), p38 (SB203580), and JNK (SP600125) were obtained from Calbiochem (San Diego, CA, USA). Inhibitors of MEK1/2 (U0126) and PI3K (LY295002) were purchased from Cell Signaling Technology (Beverly, MA, USA). All inhibitors were first dissolved in dimethyl sulfoxide (DMSO) and then diluted with culture medium with a total concentration of less than 0.1% (v/v). The primary anti-rabbit polyclonal antibodies against MMP-2, ERK1/2, p38, and JNK, and the anti-mouse monoclonal antibodies to p-ERK1/2, p-p38, and p-JNK were all purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-rabbit polyclonal antibodies to p-CREB and CREB, and the secondary antibody peroxidaseconjugated anti-mouse IgG and anti-rabbit IgG were obtained from Cell Signaling Technology (Beverly, MA, USA).
Cell culture and cell viability
Human gingival fibroblasts (HGF-1, ATCC CRL-2014) were obtained from the American Type Culture Collection (Manassas, VA, USA) and were cultured in a 5% CO 2 atmosphere at 37°C in Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 100 U/ml of penicillin A, 100 U/ml of streptomycin, and 10% heat-inactivated fetal bovine serum (FBS; Gibco, Grand Island, NY, USA). The cells were seeded at a concentration of 2 × 10 5 cells/ml per 75-cm 2 flask (SPL, Seoul, Korea) and cultured for 24 h. Cell cultures from passages 4-10 were used. Cell age did not change cell morphology or structure and had no effects on response to stimuli in P. gingivalis supernatant or protein expression in MMP-2. The effects of P. gingivalis supernatant and K. pandurata extract on cell viability were evaluated with the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) colorimetric assay (Sigma-Aldrich, St. Louis, MO, USA). K. pandurata extract was dissolved in 100% DMSO, and the stock solution of the extract at a concentration of 1,000 µg/ml was prepared in 10% DMSO. The final concentrations of the extract ranged from 1 to 50 µg/ml in the culture media, and all cells were treated with DMSO at a final concentration of 0.1%. This DMSO concentration had no effect on cell viability.
Preparation of bacterial supernatant and sample treatment P. gingivalis supernatant was prepared using a slight modification of the technique described by Chang et al. (11) . P. gingivalis strain was maintained in brain-heart infusion (BHI; Difco, Detroit, MI, USA) broth. The inoculum density was prepared in BHI broth and adjusted to a turbidity equivalent to 2 McFarland standard (6 × 10 8 CFU/ml), in order to concentrate the bacterial products in P. gingivalis supernatant. After centrifugation at 13,000 rpm for 20 min at 4°C, supernatants were filter-sterilized using a 0.2-µm filter and stored at -80°C until used. P. gingivalis supernatants were directly diluted with culture medium to a final concentration of 10%.
Cells were seeded at a concentration of 2 × 10 5 cells/ml in 6-well plates and cultured for 24 h in DMEM-FBS. After washing with Dulbecco's phosphate-buffered saline (DPBS), the cells were incubated in serum free-DMEM without P. gingivalis supernatant (negative control group), with 10% P. gingivalis supernatant (positive control group), or with 10% P. gingivalis supernatant plus treatment for 48 h. The treatment groups in this study included K. pandurata extract (1-10 µg/ml), MAPK inhibitors (U0126, SB203580, and SP600125 at a total concentration of 10 µM), PI3K inhibitor (LY295002 at 10 µM), and standard MMP inhibitor (GM6001 at 10 µM). Cell lysates and conditioned media were collected for these experiments.
Gelatin zymography MMP-2 secretion and activity in the conditioned media were evaluated by gelatin zymography. To determine MMP-2 secretion, cells were treated with P. gingivalis supernatant plus treatment (K. pandurata extract or MAPKs/PI3K/MMP inhibitors) for 48 h. Conditioned media were collected and subjected to electrophoresis with 10% SDS polyacrylamide gels containing 0.2% gelatin. Electrophoresis was run at 90 V for 1.5 h in an electrophoretic apparatus (Bio-Rad Mini Protean 3 Cell, Bio-Rad Laboratories, Hercules, CA, USA). After electrophoresis, gels were washed twice with 25 ml of 2.5% Triton X-100 on a gyratory shaker for 1 h at room temperature to remove SDS. The gel was then incubated in 25 ml of reaction buffer (50 mM Tris-HCl, pH 7.5, 10 mM CaCl 2 , 0.15 M NaCl) at 37°C for 24 h, stained with Coomassie Brilliant Blue R-250, and destained with methanol-acetic acid in water.
To detect MMP-2 activity, the conditioned media from cells treated or not treated with P. gingivalis supernatant were directly subjected to gelatin zymography. After electrophoresis, gelatin-containing gels were further treated with K. pandurata extract or protease inhibitors in 25 ml of reaction buffer and incubated at 37°C for 24 h, followed by staining and destaining treatment. The MMP-2 gelatinolytic band was detected at 67 kDa as a clear zone against the dark background. Relative band densities were analyzed by using Gel-Doc Quantity One software (BioRad Laboratories, Hercules, CA, USA).
Western blotting
To determine MMP-2 protein expression, the conditioned media from cells treated with P. gingivalis supernatant plus K. pandurata extract were concentrated with the FastCon Protein Concentration kit (Corebio, Belmont, CA, USA) and subjected to Western blotting. To determine the expression of MAPK and CREB phosphorylation, cellular lysates from the negative control, positive control, and treatment group (K. pandurata extract) were prepared and assayed by Western blot analysis. Proteins (50 µg) were resolved by 10% SDS-PAGE and transferred to nitrocellulose transfer membranes. The membranes were blocked with 5% skim milk for 1 h at room temperature and then probed with the primary anti-rabbit polyclonal antibodies to MMP-2 and p-CREB and anti-mouse monoclonal antibodies against p-ERK1/2, p-p38, and p-JNK at a 1:1000 dilution overnight at 4°C. After 3 washes, the blots were subsequently incubated with the secondary antibody peroxidase-conjugated anti-rabbit IgG or antimouse IgG at a 1:4000 dilution for 2 h at room temperature. The blots were stained with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific, Rockford, IL, USA) and visualized using an LAS 3000 Bio Imaging Analysis System (Lab Science, Fuji Film, Tokyo, Japan). Equal loading of blots was demonstrated by stripping blots and reprobing with anti-rabbit polyclonal antibodies for ERK1/2, p38, JNK, and CREB.
Reverse transcription-PCR Total RNA from P. gingivalis supernatant-treated HGF-1 cells was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol and quantified spectrophotometrically at 260/280 nm. The cDNA was synthesized by using 5 µg total RNA, oligo(dT) primers, and SuperScript III First-Strand (Invitrogen, Carlsbad, CA, USA) in a 10-µl reaction. Reverse transcription was started at 50°C for 50 min and terminated at 85°C for 5 min. The cDNA products were diluted with sterile water up to 100 µl, and PCR was conducted using 5 µl cDNA in a 25-µl reaction system with 0.5 U Takara LA Tag (Takara Bio, Shiga, Japan). The human oligonucleotide primers for MMP-2 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed according to a PCR primer selection program at the website of the Virtual Genomic Center from the GenBank database. MMP-2 primers were designed as 5'GACAGTGGATGATGCCTTTGCTCGTGCCTTCC3' for forward and 5'ATCGGCGTTCCCATACTTCA CACGGACC3' for reverse. GAPDH primers were 5'ATTGTTGCCATCAATGACCC3' for forward and 5'AGTAGAGGCAGGGATGAT3' for reverse. PCR consisted of 35 amplification cycles, and each cycle was carried out for 30 s at 94°C, 30 s at annealing temperature (69°C for MMP-2 and 48°C for GAPDH), and 1 min at 72°C in a thermal cycler (Gene Amp PCR System 2700, Applied Biosystems, CA, USA). The human GAPDH housekeeping gene was used as an internal control to standardize the relative expression levels of MMP-2. PCR products were separated electrophoretically on a 2% agarose DNA gel and stained with ethidium bromide. The stained gel was visualized by using Gel-Doc Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).
Results
Stimulating effect of P. gingivalis supernatant on MMP-2 activity and secretion in HGF-1 cells Gelatin zymography revealed a main gelatinolytic band corresponding to an approximate molecular mass of 67 kDa. To identify whether the gelatinolytic enzyme belonged to the MMP class, enzyme activity was tested against several protease inhibitors, including 4-(2-aminoethyl) benzenesulfonyl fluoride, N-ethylmaleimide, o-phenanthroline, and ethylenediaminetetraacetic acid (Fig. 1A) . The results demonstrated that, as compared with untreated cells, the enzyme was totally abolished by specific metalloproteinase inhibitors (o-phenanthroline and ethylenediaminetetraacetic acid). In contrast, the serine protease inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride and thiol protease inhibitor N-ethylmaleimide did not inhibit gelatinolytic activity. These results confirm that the gelatinolytic enzyme was MMP-2. HGF-1 cells primarily produced MMP-2, and the MMP-2 secretion was upregulated by P. gingivalis supernatant in the cells during a 48-h culture period (Fig.  1B) . At 10%, P. gingivalis supernatant optimally increased the level of MMP-2 expression, as compared with unstimulated cells.
Inhibitory effect of K. pandurata extract on MMP-2 expression in HGF-1 cells treated with P. gingivalis supernatant The use of 10% P. gingivalis supernatant to induce MMP-2 secretion in HGF-1 cells did not affect cell viability. Also, K. pandurata at concentrations up to 10 µg/ml was not cytotoxic to the viability of HGF-1 cells, or to unstimulated or P. gingivalis supernatant-stimulated cells, which suggests that the inhibitory effect of K. pandurata extract on MMP-2 expression was not attributable to its cytotoxicity (data not shown). In addition, K. pandurata extract modulated the in vitro activity and secretion of MMP-2 from the conditioned media of P. gingivalis supernatant-treated HGF-1 cells. As shown in Fig. 2A , K. pandurata dose-dependently inhibited MMP-2 activity in HGF-1 cells exposed to P. gingivalis supernatant. Incubation with the extract for 18 h effectively reduced the activity of MMP-2. K. pandurata significantly suppressed MMP-2 secretion and protein expression in P. gingivalis supernatant-treated HGF-1 cells (Figs. 2B and C) . Furthermore, K. pandurata had an inhibitory effect on transcriptional level by decreasing MMP-2 mRNA expression in HGF-1 cells in response to P. gingivalis supernatant (Fig. 2D ).
Inhibitory effect of K. pandurata extract on P. gingivalis supernatant-induced activation of MAPK and CREB phosphorylation in HGF-1 cells
The decrease in MMP-2 mRNA caused by K. pandurata extract suggests that the inhibitory effect of the extract is tightly regulated at the transcriptional level. Inhibition of MMP-2 expression via signaling pathways in P. gingivalis supernatant-treated HGF-1 cells was preliminarily examined with gelatin zymography by using the specific mitogen-activated protein kinase (MAPK) inhibitors U0126, SB203580, and SP600125 and the phosphatidylinositol-3 kinase (PI3K) inhibitor LY294002. The results showed that all inhibitors significantly reduced MMP-2 secretion in HGF-1 cells exposed to P. gingivalis supernatant (Fig. 3A) . The reference MMP inhibitor, GM6001, also specifically attenuated MMP-2 expression in P. gingivalis supernatant-treated HGF-1 cells.
Next, we used a Western blot assay to elucidate the molecular mechanisms underlying K. pandurata inhibition of MAPK signaling pathways involved in MMP-2 gene expression in P. gingivalis supernatant-treated HGF-1 Fig. 3 Effects of signaling inhibitors on MMP-2 expression in P. gingivalis supernatant-treated HGF-1 cells (A). Cells treated with P. gingivalis supernatant (10%) and a MAPK inhibitor (U0126, SB203580, and SP600125), PI3K inhibitor (LY600125), or standard MMP inhibitor (GM600125) at a total concentration of 10 µM were cultured for 48 h. Cells not treated with inhibitor or P. gingivalis supernatant were used as controls. The level of MMP-2 secreted from culture media was assayed by gelatin zymography. Effect of K. pandurata extract on P. gingivalis supernatant-induced activation of MAPK and CREB phosphorylation in HGF-1 cells (B-C). Cells treated with K. pandurata extract (2, 5, and 10 µg/ml) and P. gingivalis supernatant (10%) were cultured for 48 h. Cells not treated with K. pandurata extract or P. gingivalis supernatant were used as controls. To investigate MAPK and CREB phosphorylation, cell lysates were analyzed by Western blotting using (B) p-ERK1/2, p-p38, p-JNK, and (C) p-CREB antibodies. Membranes were stripped and reprobed using an antibody against each protein as a control for equal loading.
cells. Exposure of HGF-1 cells to P. gingivalis supernatant (10%) enhanced ERK1/2, p38, and JNK phosphorylation, as compared with the untreated controls. Treatment with K. pandurata extract dose-dependently suppressed expression of all MAPK phosphorylation in P. gingivalis supernatant-treated HGF-1 cells, as compared with untreated control cells (Fig. 3B) . It has been reported that K. pandurata extract has a stronger inhibitory effect on JNK phosphorylation than on ERK1/2 and p38 phosphorylation. CREB is a regulatory element in the promoter regions of human MMP genes, including the MMP-2 gene (14) . A Western blot assay was used to test the effect of K. pandurata extract on P. gingivalis supernatant-stimulated activation of CREB phosphorylation in HGF-1 cells. K. pandurata extract significantly decreased phosphorylated CREB in HGF-1 cells treated with P. gingivalis supernatant (Fig. 3C ).
Discussion
Considerable research has been devoted to the use of therapeutic agents in the management of periodontitis. Chronic periodontitis caused by the interaction between host responses and periodontopathogens is associated with excess production of inflammatory mediators, including MMPs (15) . Only a few synthetic MMP inhibitors, such as the tetracycline groups, have been reported as possible treatments for periodontitis (12, 16) . However, their clinical efficacy has not been established. Some natural compounds, including Lupinus albus extract, cranberry constituents, and hop polyphenols from Humulus lupulus L. (Cannabinaceae), have been effective in the in vitro treatment of periodontal inflammation by attenuating expression of MMPs, prostaglandin, and cytokines (17) (18) (19) (20) .
In this study, we observed an inhibitory effect of ethanolic K. pandurata extract on signaling pathways mediating MMP-2 expression in P. gingivalis supernatant-treated human gingival fibroblasts. Gingival fibroblasts naturally produce MMPs, the synthesis of which is stimulated by periodontopathogens and their products, including P. gingivalis lipopolysaccharide and supernatant, Aggregatibacter actinomycetemcomitans lipopolysaccharide, and Treponema denticola lipopolysaccharide (21) (22) (23) (24) . P. gingivalis is a Gram-negative anaerobic bacterium found in periodontal pockets and has been identified as an important pathogen in periodontal disease. Secreted virulence factors, including lipopolysaccharide and supernatant from P. gingivalis, alter MMP secretion and activate host cells, resulting in tissue degradation. HGF-1 cells, i.e., normal human gingival fibroblasts, also produce a small amount of MMP-2; thus, in this study, P. gingivalis supernatant was added to culture cells to increase the level of MMP-2. Gelatin zymography revealed that P. gingivalis supernatant treatment of HGF-1 cells enhanced major MMP-2 expression (Fig. 1) , suggesting that P. gingivalis supernatant is involved in periodontitis progression via the production of MMP-2. Our results were similar to those of a previous study, which demonstrated that MMP-2 expression was elevated after treatment with P. gingivalis supernatant in human periodontal ligament, oral epithelial, and osteosarcoma cells (9, 11, 25) . However, the specific mechanisms by which these factors mediate cellular MMP-2 secretion are unclear. A previous report described a mechanism by which periodontal pathogens might mediate connective tissue degradation in periodontal disease. The researchers suggested that cell wall antigens stimulate circulating mononuclear phagocytes to produce cytokines, which in turn induce MMP synthesis, thereby initiating extracellular matrix degradation (26) .
The ethanolic K. pandurata extract reduced MMP-2 activity and secretion in a dose-dependent manner ( Figs.  2A and B) . Increased MMP activity is associated with various pathological conditions during periodontitis progression. K. pandurata extract has the potential to directly inhibit enzyme activity ( Fig. 2A) . Because of its potent inhibitory effects against both MMP-2 activity and secretion, K. pandurata extract is a potential agent for treating and preventing periodontal inflammation. Furthermore, K. pandurata extract decreased MMP-2 protein and gene expression in P. gingivalis-treated HGF-1 cells (Figs. 2C and D) . It is thought that K. pandurata extract may modulate the regulation of MMP-2 expression at the transcriptional level. However, MMP regulation is complex, due to the involvement of multiple pathways, including cell responses to regulatory signals, signal transduction, transcription induction, post-transcriptional processing, MMP activation, transport, and secretion (14) .
The MAPK signaling pathways play a key role in regulating expression and activating major transcription factors in several MMP genes. To date, only a few studies have observed involvement of MAPK and PI3K signaling pathways in the regulation of MMP-2 expression in human periodontal cell lines (11, 27) . However, the mechanisms and signaling pathways involved in MMP-2 expression in HGF-1 cells exposed to P. gingivalis supernatant remain unclear. In the present study, gelatin zymography revealed that the specific kinase inhibitors MAPK and PI3K attenuated MMP-2 secretion, indicating that these signaling pathways partially mediate MMP-2 expression in P. gingivalis-treated HGF-1 cells (Fig. 3A) . P. gingivalis also activated phosphorylation of MAPK members, including ERK1/2, p38, and JNK, in HGF-1 cells (Fig. 3B) . We noted that K. pandurata treatment more strongly inhibited phosphorylated JNK than ERK1/2 and p38 phosphorylation, in HGF-1 cells exposed to P. gingivalis supernatant (Fig. 3B) . These results suggest that K. pandurata extract suppresses MMP-2 gene expression by downregulating major JNK signaling. This resembles the mechanisms of action of other naturally occurring antiinflammatory flavonoid compounds, such as luteolin, quercetin, genistein, and quercetagetin, which inhibit E. coli lipopolysaccharide-stimulated MAPK activation in human gingival fibroblasts (28) (29) .
At the transcriptional level, P. gingivalis supernatant effectively enhanced expression of CREB phosphorylation, one of the regulatory elements in the promoter regions of the MMP-2 gene. It has been noted that activation of p38 kinase results in phosphorylation of CREB (30) , suggesting that P. gingivalis supernatant induces expression of phosphorylated CREB via p38 kinase signaling in HGF-1 cells. Activation of PI3K also leads to phosphorylation of Akt, which plays a critical role in the activation of transcription factor CREB. In the present study, the PI3K inhibitor LY295002 partially inhibited MMP-2 secretion in HGF-1 cells treated with P. gingivalis supernatant (Fig.  3A) . Chan et al. (31) reported that CREB signaling was stimulated by protease-activated receptors during wound healing and inflammatory responses in human gingival tissues. In the present study, treatment with K. pandurata extract dose-dependently decreased phosphorylated CREB (Fig. 3C) , suggesting that K. pandurata extract reduced MMP-2 gene expression via inhibition of the CREB and JNK signaling pathways. The importance of the CREB element in the promoter of the MMP-2 gene in P. gingivalis supernatant-treated HGF-1 cells highlights the need to elucidate the mechanisms underlying CREB/MAPKs and PI3K/Akt signaling and identify the transcription factors affected by P. gingivalis and K. pandurata treatment.
In sum, our findings provide insight into the molecular mechanisms by which ethanolic K. pandurata extract blocks P. gingivalis supernatant-stimulated MMP-2 expression in human gingival fibroblasts. K. pandurata extract inhibited P. gingivalis supernatant-stimulated MMP-2 protein and gene expression via modulation of CREB signaling, which may be facilitated by attenuation of JNK phosphorylation. Thus, K. pandurata Roxb. appears to be a potent MMP inhibitor that may prove useful in controlling the destruction of periodontal tissue.
